F.D.A. Approves Narcan for Over-the-Counter Salesnews2023-03-29T12:45:40+00:00March 29th, 2023|The New York Times|
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles.news2023-03-28T17:05:40+00:00March 28th, 2023|The New York Times|
The Adderall Shortage Reflects Bad Drug Policynews2023-03-25T13:00:09+00:00March 25th, 2023|The New York Times|
More Doctors Can Now Prescribe Buprenorphine to Opioid Users. Will It Help?news2023-03-03T08:00:11+00:00March 3rd, 2023|The New York Times|
New Approaches to the Drug Overdose Crisisnews2023-03-02T20:17:00+00:00March 2nd, 2023|The New York Times|
Opioid Distributors Cleared of Liability to Georgia Families Ravaged by Addictionnews2023-03-02T02:54:45+00:00March 2nd, 2023|The New York Times|
Biden Proposal Would Ban Online Prescribing of Certain Drugsnews2023-02-25T10:49:56+00:00February 25th, 2023|The New York Times|
A Fraught New Frontier in Telehealth: Ketaminenews2023-02-20T08:00:06+00:00February 20th, 2023|The New York Times|
Narcan Is Safe to Sell Over the Counter, Advisers to the FDA Concludenews2023-02-16T01:23:11+00:00February 16th, 2023|The New York Times|
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisisnews2022-12-29T23:46:45+00:00December 29th, 2022|The New York Times|
